Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 1;199(1):292-303.
doi: 10.4049/jimmunol.1600483. Epub 2017 May 22.

FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation

Ádám I Csincsi  1 , Zsóka Szabó  1 , Zsófia Bánlaki  1 , Barbara Uzonyi  2 , Marcell Cserhalmi  1 , Éva Kárpáti  1 , Agustín Tortajada  3   4 , Joseph J E Caesar  5 , Zoltán Prohászka  6 , T Sakari Jokiranta  7 , Susan M Lea  5 , Santiago Rodríguez de Córdoba  3   4 , Mihály Józsi  8
Affiliations
Free article

FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation

Ádám I Csincsi et al. J Immunol. .
Free article

Abstract

Factor H-related protein (FHR) 1 is one of the five human FHRs that share sequence and structural homology with the alternative pathway complement inhibitor FH. Genetic studies on disease associations and functional analyses indicate that FHR-1 enhances complement activation by competitive inhibition of FH binding to some surfaces and immune proteins. We have recently shown that FHR-1 binds to pentraxin 3. In this study, our aim was to investigate whether FHR-1 binds to another pentraxin, C-reactive protein (CRP), analyze the functional relevance of this interaction, and study the role of FHR-1 in complement activation and regulation. FHR-1 did not bind to native, pentameric CRP, but it bound strongly to monomeric CRP via its C-terminal domains. FHR-1 at high concentration competed with FH for CRP binding, indicating possible complement deregulation also on this ligand. FHR-1 did not inhibit regulation of solid-phase C3 convertase by FH and did not inhibit terminal complement complex formation induced by zymosan. On the contrary, by binding C3b, FHR-1 allowed C3 convertase formation and thereby enhanced complement activation. FHR-1/CRP interactions increased complement activation via the classical and alternative pathways on surfaces such as the extracellular matrix and necrotic cells. Altogether, these results identify CRP as a ligand for FHR-1 and suggest that FHR-1 enhances, rather than inhibits, complement activation, which may explain the protective effect of FHR-1 deficiency in age-related macular degeneration.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms

  NODES
Association 3
INTERN 2
twitter 2